quinoxalines has been researched along with Trigeminal Neuralgia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Mashimo, T; Nakae, A; Nakai, K; Oba, S; Ueda, K | 1 |
Ikeda, M; Lipski, J; Matsumoto, S; Takeda, M; Tanimoto, T | 1 |
2 other study(ies) available for quinoxalines and Trigeminal Neuralgia
Article | Year |
---|---|
5-HT2C receptor agonists attenuate pain-related behaviour in a rat model of trigeminal neuropathic pain.
Topics: Animals; Behavior, Animal; Dose-Response Relationship, Drug; Ethylamines; Indoles; Injections, Spinal; Male; Neuralgia; Pain Measurement; Pain Threshold; Physical Stimulation; Pyrazines; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2C; Serotonin Antagonists; Serotonin Receptor Agonists; Spiro Compounds; Sulfonamides; Trigeminal Neuralgia | 2010 |
Changes of the excitability of rat trigeminal root ganglion neurons evoked by alpha(2)-adrenoreceptors.
Topics: Action Potentials; Adrenergic alpha-Agonists; Animals; Animals, Newborn; Brimonidine Tartrate; Cell Membrane; Cells, Cultured; Clonidine; Gene Expression Regulation; Ion Channels; Neural Inhibition; Neurons, Afferent; Protein Isoforms; Quinoxalines; Rats; Receptors, Adrenergic, alpha-2; RNA, Messenger; Trigeminal Ganglion; Trigeminal Neuralgia | 2002 |